Evgen Pharma (GB:TCF) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TheraCryf plc, renamed from Evgen Pharma and specialising in oncology and neuropsychiatry drug development, will release its full-year financial results on May 28, 2024. A live presentation hosted by CEO Huw Jones and CFO Toni Hänninen will be accessible via the Investor Meet Company platform, where shareholders can engage and pose questions.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.